Developer docs
API playgroundTry for free, no card

Search company profiles

IPRO

Full company profile

uuid000cvp9

Namestring
IPRO
Legal namestring
IPRO
Websiteurl
ipro.org
Company typeenum
Private
Founded yearint
1984
Descriptiontext

IPRO is a national, not-for-profit healthcare quality improvement organization incorporated in 1983 and operational since 1984. Headquartered in Jericho, New York, with regional offices in Albany (NY) and Hamilton (NJ), IPRO employs more than 300 full-time professionals and maintains a network of 500+ board-certified physician consultants and subject-matter specialists spanning epidemiology, biostatistics, health informatics, pharmacy, nursing, coding, and quality improvement. The organization operates across nearly 100 state and federal programs in 32 states plus the District of Columbia, serving CMS, state departments of health, managed care plans, healthcare providers, and consumers.

The company's core offerings are organized around federally and state-mandated quality oversight. IPRO is the designated CMS Quality Innovation Network-Quality Improvement Organization (QIN-QIO) for both Region 1 (Northeast) and Region 2 (Mid-Atlantic) under the 13th Statement of Work, with contracts running through May 2030 and covering 24% of the nation's Medicare beneficiaries. It operates four End-Stage Renal Disease (ESRD) Networks supporting approximately 60,000+ dialysis patients and 900+ Medicare-certified facilities. IPRO serves as an External Quality Review Organization (EQRO) for Medicaid managed care in 21+ states, working with more than 150 managed care plans, and is a certified Independent Dispute Resolution Entity under the No Surprises Act. Supporting technology includes an in-house software development team maintaining encounter data warehouses for multiple states, the Kidney Transplant Compare mobile application, and quality measurement and reporting systems. Strategic content assets include the Quality Watch Podcast, Healthy Insights Newsletter, IPRO-authored scholarly articles, and Project Firstline infection prevention training delivered to approximately 165,000 healthcare workers.

IPRO's revenue model is entirely contract-based and government-anchored. Primary streams are federal contracts with CMS (QIN-QIO, ESRD Networks, IDR) and state Medicaid contracts (EQRO, compliance audits, utilization review, state-directed payment assessments, state healthcare assessments). Provider-facing technical assistance and consulting engagements constitute a smaller, supplementary stream. As a 501(c)(3)-style non-profit, IPRO has no equity shareholders, no public ticker, and does not disclose revenue; pricing is set through federal and state procurement processes rather than published rates. The organization reinvests contract revenue into program delivery, content production, workforce, and SOC 2 Type 2 / HIPAA-compliant infrastructure.

Short descriptiontext

IPRO is a national non-profit healthcare quality improvement organization serving CMS, 21+ state health departments, 150+ managed care plans, and providers across 32 states via QIN-QIO contracts, four ESRD Networks, EQRO services, and certified IDR work.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersNew Hyde Park, United States
HQ citystring
New Hyde Park
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare quality improvement, quality improvement organization, external quality review, end stage renal disease, utilization review services
Product category
Healthcare Quality Improvement Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Federal Government Contracts
TypeOthers
Description

IPRO generates primary revenue through federal contracts with CMS for QIN-QIO programs (Regions 1 and 2 through 2030), ESRD Network Programs, and other healthcare quality improvement initiatives. Contract terms run through May 2030.

ipro.org
2State Government Contracts
TypeOthers
Description

Revenue from state departments of health for Medicaid EQRO services, state healthcare assessments, compliance audits, and other quality improvement programs across 21+ states.

ipro.org
3External Quality Review Organization (EQRO)
TypeOthers
Description

IPRO serves as EQRO for multiple states, evaluating quality of healthcare services provided to Medicaid Managed Care enrollees, generating revenue through contractual arrangements with state Medicaid programs.

ipro.org
4Healthcare Quality Improvement Consulting
TypeProfessional Services
Description

IPRO provides consulting services to healthcare providers, including technical assistance, training programs, and quality improvement consultation for nursing homes, hospitals, and outpatient clinical practices.

ipro.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Kidney Transplant Compare
Description

Mobile application and website that empowers kidney patients to find transplant centers by providing comparative data on programs, allowing users to filter by location, medical selection criteria, outcomes, and support services.

esrd.ipro.org
+2 more records
Core offering1 text field

IPRO is a non-profit healthcare quality improvement organization that delivers contracted services to federal and state governments, healthcare providers, and managed care plans. Its core offerings include the Medicare Quality Innovation Network-Quality Improvement Organization (QIN-QIO) program for CMS Regions 1 and 2, ESRD Network Programs for End-Stage Renal Disease patients, External Quality Review Organization (EQRO) services for state Medicaid programs, Independent Dispute Resolution under the No Surprises Act, Independent Review of Appeals, and supporting digital tools such as the Kidney Transplant Compare mobile application.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 24% of nation's Medicare beneficiaries served through QIN-QIO programs
+3 more records
Product overview1 text field

IPRO is a healthcare quality improvement organization that operates as a platform of interconnected programs and services designed to improve healthcare outcomes across various populations. The core offerings include federal quality improvement contracts (QIN-QIO, ESRD programs, EQRO services) that provide regulatory compliance and performance improvement support, along with dispute resolution services (Independent Review of Appeals, IDR). Supporting these core services are digital tools including the Kidney Transplant Compare mobile application and content resources such as the Quality Watch Podcast and Healthy Insights Newsletter. The organization functions as both a direct service provider and an advisory/educational resource for healthcare stakeholders including CMS, state health departments, providers, and patients.

Product and service1 record
1Medicare Quality Innovation Network - Quality Improvement Organization (QIN-QIO)
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-26
Description

Healthcentric Advisors, based in Rhode Island, serves as a subcontractor to IPRO under the CMS QIN-QIO contract for Region 1 (Northeast). Together with IPRO and Qlarant, they form a collaboration of three organizations with decades of experience serving as Medicare QIOs, providing direct technical assistance, advanced data analytics, evidence-based intervention recommendations, and customized training to healthcare providers.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-26
Description

Qlarant, based in Maryland, serves as a subcontractor to IPRO under the CMS QIN-QIO contract for Region 1 (Northeast). Together with IPRO and Healthcentric Advisors, they form a collaboration providing multidisciplinary teams of experienced healthcare quality improvement specialists for direct technical assistance and resources to nursing homes, hospitals, and outpatient practices.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

IPRO was selected by New York State to implement Project Firstline, a CDC-led project bringing critical infection prevention and control training to frontline healthcare staff in NYS dialysis centers. The project is sponsored by Health Research Inc. (HRI) which administers funding for NYSDOH public health goals.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Health Research Inc. (HRI) administers funding to further public health goals of the NYS Department of Health and other entities. HRI sponsors Project Firstline, the CDC-led infection prevention training program implemented by IPRO in New York State dialysis centers.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

CDC leads Project Firstline, an initiative that has developed more than 900 educational products and training materials and hosted more than 2,400 educational events reaching approximately 165,000 healthcare workers as of December 2023. IPRO implements this program in New York State dialysis centers.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

CMS awarded IPRO contracts to serve as the Medicare Quality Innovation Network-Quality Improvement Organization (QIN-QIO) for both the Northeast (Region 1) and Mid-Atlantic (Region 2) under the 13th Statement of Work. Contracts run through May 2030 and cover 24% of the nation's Medicare beneficiaries.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

IPRO Senior Director Mary Dramitinos participates on a Technical Expert Panel for Medicaid Total Cost of Care measure development, which CORE is developing with CMS. The TEP provides guidance on measure design, methodology, and implementation considerations.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Patient advocacy group that provided direct input into the development of Kidney Transplant Compare application, ensuring the 131 data points included reflect information most important to patients.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

HLM leads the Public Education for the Living Organ Donation Reimbursement Program (LODRP) funded by HRSA. IPRO Director Caroline Sanner serves on the Advisory Board supporting this project's goal to increase awareness and equitable access to living organ donation reimbursement, particularly among medically underserved communities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner in the Public Education for the Living Organ Donation Reimbursement Program (LODRP) alongside Health Literacy Media and Houston Methodist Hospital, working to increase awareness of and access to living organ donation financial support.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner in the Public Education for the Living Organ Donation Reimbursement Program (LODRP) alongside Health Literacy Media and National Kidney Foundation, contributing to outreach and education initiatives for living organ donation.

12National Association of Independent Review Organizations (NAIRO)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Industry trade association dedicated to upholding integrity of medical peer review and utilization review processes. IPRO's Allison Xiong, Ph.D. serves as Chair of the Technology/AI/Cybersecurity Committee, engaging in monthly meetings with industry experts to discuss latest developments in AI and emerging technologies.

ipro.org
13National Association of Independent Review Organizations (NAIRO)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

IPRO's Debora Santiago serves as Chair of NAIRO's Legislative Committee, attending monthly meetings to provide members with updates on trends and pending legislation. IPRO contributes to safeguarding important review processes through this industry association.

ipro.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Consensus-based entity certified by CMS to bring together experts in healthcare quality improvement to endorse quality measures. Multiple IPRO employees serve on Pre-Rulemaking Measure Review (PRMR) committees including Hospital, Clinician, and Post-Acute Care & Long-Term Care Advisory Groups.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

IMPAQ International is a research and analytics firm that performs healthcare quality measurement, program evaluation, and policy analysis for federal agencies. It competes with IPRO for healthcare QI contracts but operates as a for-profit with broader international policy work.

TypeDirect peer
Description

MetaStar is a Wisconsin-based non-profit QIO providing healthcare quality improvement, EQRO, and utilization review services to state Medicaid agencies and CMS. It is comparable to IPRO in scope, customer base (state Medicaid programs), and contract-based delivery model.

TypeBroad incumbent
Description

CMS is the federal agency that funds and oversees IPRO's largest contracts (QIN-QIO, ESRD Networks). While not a commercial competitor, CMS shapes the regulatory environment IPRO operates within and represents the dominant counterparty in IPRO's revenue model.

TypeDirect peer
Description

Stratis Health is a Minnesota-based non-profit QIO focused on improving healthcare quality in the Upper Midwest. It is a direct peer in CMS QIN-QIO and EQRO services with comparable customer base and contract-driven business model.

TypeDirect peer
Description

Qlarant is a Maryland-based non-profit QIO that serves as IPRO's subcontractor on the Region 1 QIN-QIO contract. It provides comparable healthcare quality improvement, case review, and EQRO services to federal and state clients across multiple US regions.

TypeBroad incumbent
Description

Mathematica is a major US policy research and data analytics firm that performs healthcare quality measurement, program evaluation, and CMS technical assistance work. It is comparable to IPRO in healthcare analytics and federal government contracts but operates more broadly across policy areas.

TypeDirect peer
Description

Telligen is a non-profit healthcare quality improvement organization serving as a CMS QIN-QIO and ESRD Network operator in multiple US regions. It competes with IPRO in federal healthcare QI procurements and offers comparable population health and quality measurement services.

TypeDirect peer
Description

Healthcentric Advisors is a Rhode Island-based non-profit QIO that partners with IPRO on the Region 1 QIN-QIO contract. It offers directly comparable Medicare quality improvement, patient safety, and clinical analytics services with similar customer segments and contract structure.

TypeDirect peer
Description

Alliant Health Solutions (formerly Georgia Medical Care Foundation) is a non-profit QIO serving as a CMS QIN-QIO contractor across multiple southeastern states. It directly competes with IPRO in federal quality improvement procurements and operates an ESRD Network.

TypeDirect peer
Description

HSAG is one of the largest US non-profit QIOs, serving as a QIN-QIO and EQRO contractor across multiple western and southwestern states. It is a direct competitor to IPRO in federal and state healthcare quality improvement procurements with comparable services.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

IPRO

Healthcare Quality Improvement Servicesipro.org

IPRO is a national non-profit healthcare quality improvement organization serving CMS, 21+ state health departments, 150+ managed care plans, and providers across 32 states via QIN-QIO contracts, four ESRD Networks, EQRO services, and certified IDR work.

What IPRO does

IPRO is a national, not-for-profit healthcare quality improvement organization incorporated in 1983 and operational since 1984. Headquartered in Jericho, New York, with regional offices in Albany (NY) and Hamilton (NJ), IPRO employs more than 300 full-time professionals and maintains a network of 500+ board-certified physician consultants and subject-matter specialists spanning epidemiology, biostatistics, health informatics, pharmacy, nursing, coding, and quality improvement. The organization operates across nearly 100 state and federal programs in 32 states plus the District of Columbia, serving CMS, state departments of health, managed care plans, healthcare providers, and consumers.

The company's core offerings are organized around federally and state-mandated quality oversight. IPRO is the designated CMS Quality Innovation Network-Quality Improvement Organization (QIN-QIO) for both Region 1 (Northeast) and Region 2 (Mid-Atlantic) under the 13th Statement of Work, with contracts running through May 2030 and covering 24% of the nation's Medicare beneficiaries. It operates four End-Stage Renal Disease (ESRD) Networks supporting approximately 60,000+ dialysis patients and 900+ Medicare-certified facilities. IPRO serves as an External Quality Review Organization (EQRO) for Medicaid managed care in 21+ states, working with more than 150 managed care plans, and is a certified Independent Dispute Resolution Entity under the No Surprises Act. Supporting technology includes an in-house software development team maintaining encounter data warehouses for multiple states, the Kidney Transplant Compare mobile application, and quality measurement and reporting systems. Strategic content assets include the Quality Watch Podcast, Healthy Insights Newsletter, IPRO-authored scholarly articles, and Project Firstline infection prevention training delivered to approximately 165,000 healthcare workers.

IPRO's revenue model is entirely contract-based and government-anchored. Primary streams are federal contracts with CMS (QIN-QIO, ESRD Networks, IDR) and state Medicaid contracts (EQRO, compliance audits, utilization review, state-directed payment assessments, state healthcare assessments). Provider-facing technical assistance and consulting engagements constitute a smaller, supplementary stream. As a 501(c)(3)-style non-profit, IPRO has no equity shareholders, no public ticker, and does not disclose revenue; pricing is set through federal and state procurement processes rather than published rates. The organization reinvests contract revenue into program delivery, content production, workforce, and SOC 2 Type 2 / HIPAA-compliant infrastructure.

IPRO firmographics

Firmographics
Name
IPRO
Legal name
IPRO
Website
https://ipro.org
Company type
Private
Founded year
1984
Operating status
Operating
Headcount range
251–500 employees
Short description
IPRO is a national non-profit healthcare quality improvement organization serving CMS, 21+ state health departments, 150+ managed care plans, and providers across 32 states via QIN-QIO contracts, four ESRD Networks, EQRO services, and certified IDR work.
Ownership category
akta.pro rank

Where IPRO is headquartered

Location

Headquarters

HQ city
New Hyde Park
HQ country
United States
HQ region
North America

Offices3 records

Markets served

IPRO business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Federal Government Contracts: IPRO generates primary revenue through federal contracts with CMS for QIN-QIO programs (Regions 1 and 2 through 2030), ESRD Network Programs, and other healthcare quality improvement initiatives. Contract terms run through May 2030.
  2. State Government Contracts: Revenue from state departments of health for Medicaid EQRO services, state healthcare assessments, compliance audits, and other quality improvement programs across 21+ states.
  3. External Quality Review Organization (EQRO): IPRO serves as EQRO for multiple states, evaluating quality of healthcare services provided to Medicaid Managed Care enrollees, generating revenue through contractual arrangements with state Medicaid programs.
  4. Healthcare Quality Improvement Consulting: IPRO provides consulting services to healthcare providers, including technical assistance, training programs, and quality improvement consultation for nursing homes, hospitals, and outpatient clinical practices.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

IPRO product offering

Product offering

Core offering

IPRO is a non-profit healthcare quality improvement organization that delivers contracted services to federal and state governments, healthcare providers, and managed care plans. Its core offerings include the Medicare Quality Innovation Network-Quality Improvement Organization (QIN-QIO) program for CMS Regions 1 and 2, ESRD Network Programs for End-Stage Renal Disease patients, External Quality Review Organization (EQRO) services for state Medicaid programs, Independent Dispute Resolution under the No Surprises Act, Independent Review of Appeals, and supporting digital tools such as the Kidney Transplant Compare mobile application.

Product overview

IPRO is a healthcare quality improvement organization that operates as a platform of interconnected programs and services designed to improve healthcare outcomes across various populations. The core offerings include federal quality improvement contracts (QIN-QIO, ESRD programs, EQRO services) that provide regulatory compliance and performance improvement support, along with dispute resolution services (Independent Review of Appeals, IDR). Supporting these core services are digital tools including the Kidney Transplant Compare mobile application and content resources such as the Quality Watch Podcast and Healthy Insights Newsletter. The organization functions as both a direct service provider and an advisory/educational resource for healthcare stakeholders including CMS, state health departments, providers, and patients.

Differentiator

Problem solved

Functional benefit

Brands

  • Kidney Transplant Compare: Mobile application and website that empowers kidney patients to find transplant centers by providing comparative data on programs, allowing users to filter by location, medical selection criteria, outcomes, and support services.
  • Quality Watch Podcast
  • Healthy Insights Newsletter

Products and services

  • Medicare Quality Innovation Network - Quality Improvement Organization (QIN-QIO)

Quantifiable outcome

  • 24% of nation's Medicare beneficiaries served through QIN-QIO programs
  • +3 more outcomes

Companies that use IPRO

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles4 records

IPRO technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

IPRO partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core, flagship and minor.

  • Healthcentric AdvisorscoreStrategic or Co-development Partner · 26 March 2026Healthcentric Advisors, based in Rhode Island, serves as a subcontractor to IPRO under the CMS QIN-QIO contract for Region 1 (Northeast). Together with IPRO and Qlarant, they form a collaboration of three organizations with decades of experience serving as Medicare QIOs, providing direct technical assistance, advanced data analytics, evidence-based intervention recommendations, and customized training to healthcare providers.
  • QlarantcoreStrategic or Co-development Partner · 26 March 2026Qlarant, based in Maryland, serves as a subcontractor to IPRO under the CMS QIN-QIO contract for Region 1 (Northeast). Together with IPRO and Healthcentric Advisors, they form a collaboration providing multidisciplinary teams of experienced healthcare quality improvement specialists for direct technical assistance and resources to nursing homes, hospitals, and outpatient practices.
  • New York State Department of HealthcoreStrategic or Co-development PartnerIPRO was selected by New York State to implement Project Firstline, a CDC-led project bringing critical infection prevention and control training to frontline healthcare staff in NYS dialysis centers. The project is sponsored by Health Research Inc. (HRI) which administers funding for NYSDOH public health goals.
  • Health Research Inc. (HRI)coreStrategic or Co-development PartnerHealth Research Inc. (HRI) administers funding to further public health goals of the NYS Department of Health and other entities. HRI sponsors Project Firstline, the CDC-led infection prevention training program implemented by IPRO in New York State dialysis centers.
  • Centers for Disease Control and Prevention (CDC)coreStrategic or Co-development PartnerCDC leads Project Firstline, an initiative that has developed more than 900 educational products and training materials and hosted more than 2,400 educational events reaching approximately 165,000 healthcare workers as of December 2023. IPRO implements this program in New York State dialysis centers.
  • Centers for Medicare & Medicaid Services (CMS)flagshipStrategic or Co-development PartnerCMS awarded IPRO contracts to serve as the Medicare Quality Innovation Network-Quality Improvement Organization (QIN-QIO) for both the Northeast (Region 1) and Mid-Atlantic (Region 2) under the 13th Statement of Work. Contracts run through May 2030 and cover 24% of the nation's Medicare beneficiaries.
  • Yale New Haven Health Services Corporation/Center for Outcomes Research and Evaluation (CORE)coreStrategic or Co-development PartnerIPRO Senior Director Mary Dramitinos participates on a Technical Expert Panel for Medicaid Total Cost of Care measure development, which CORE is developing with CMS. The TEP provides guidance on measure design, methodology, and implementation considerations.
  • Chronic Kidney Disease ChampionsminorStrategic or Co-development PartnerPatient advocacy group that provided direct input into the development of Kidney Transplant Compare application, ensuring the 131 data points included reflect information most important to patients.
  • Health Literacy Media (HLM)coreStrategic or Co-development PartnerHLM leads the Public Education for the Living Organ Donation Reimbursement Program (LODRP) funded by HRSA. IPRO Director Caroline Sanner serves on the Advisory Board supporting this project's goal to increase awareness and equitable access to living organ donation reimbursement, particularly among medically underserved communities.
  • National Kidney FoundationcoreStrategic or Co-development PartnerPartner in the Public Education for the Living Organ Donation Reimbursement Program (LODRP) alongside Health Literacy Media and Houston Methodist Hospital, working to increase awareness of and access to living organ donation financial support.
  • Houston Methodist HospitalcoreStrategic or Co-development PartnerPartner in the Public Education for the Living Organ Donation Reimbursement Program (LODRP) alongside Health Literacy Media and National Kidney Foundation, contributing to outreach and education initiatives for living organ donation.
  • National Association of Independent Review Organizations (NAIRO)minorStrategic or Co-development PartnerIndustry trade association dedicated to upholding integrity of medical peer review and utilization review processes. IPRO's Allison Xiong, Ph.D. serves as Chair of the Technology/AI/Cybersecurity Committee, engaging in monthly meetings with industry experts to discuss latest developments in AI and emerging technologies.
  • National Association of Independent Review Organizations (NAIRO)minorStrategic or Co-development PartnerIPRO's Debora Santiago serves as Chair of NAIRO's Legislative Committee, attending monthly meetings to provide members with updates on trends and pending legislation. IPRO contributes to safeguarding important review processes through this industry association.
  • Partnership for Quality MeasurementcoreStrategic or Co-development PartnerConsensus-based entity certified by CMS to bring together experts in healthcare quality improvement to endorse quality measures. Multiple IPRO employees serve on Pre-Rulemaking Measure Review (PRMR) committees including Hospital, Clinician, and Post-Acute Care & Long-Term Care Advisory Groups.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

IPRO competitors and assessment

Company assessment

Emerging players

  • IMPAQ International: IMPAQ International is a research and analytics firm that performs healthcare quality measurement, program evaluation, and policy analysis for federal agencies. It competes with IPRO for healthcare QI contracts but operates as a for-profit with broader international policy work.

Direct peers

  • MetaStar: MetaStar is a Wisconsin-based non-profit QIO providing healthcare quality improvement, EQRO, and utilization review services to state Medicaid agencies and CMS. It is comparable to IPRO in scope, customer base (state Medicaid programs), and contract-based delivery model.
  • Stratis Health: Stratis Health is a Minnesota-based non-profit QIO focused on improving healthcare quality in the Upper Midwest. It is a direct peer in CMS QIN-QIO and EQRO services with comparable customer base and contract-driven business model.
  • Qlarant: Qlarant is a Maryland-based non-profit QIO that serves as IPRO's subcontractor on the Region 1 QIN-QIO contract. It provides comparable healthcare quality improvement, case review, and EQRO services to federal and state clients across multiple US regions.
  • Telligen: Telligen is a non-profit healthcare quality improvement organization serving as a CMS QIN-QIO and ESRD Network operator in multiple US regions. It competes with IPRO in federal healthcare QI procurements and offers comparable population health and quality measurement services.
  • Healthcentric Advisors: Healthcentric Advisors is a Rhode Island-based non-profit QIO that partners with IPRO on the Region 1 QIN-QIO contract. It offers directly comparable Medicare quality improvement, patient safety, and clinical analytics services with similar customer segments and contract structure.
  • Alliant Health Solutions: Alliant Health Solutions (formerly Georgia Medical Care Foundation) is a non-profit QIO serving as a CMS QIN-QIO contractor across multiple southeastern states. It directly competes with IPRO in federal quality improvement procurements and operates an ESRD Network.
  • Health Services Advisory Group (HSAG): HSAG is one of the largest US non-profit QIOs, serving as a QIN-QIO and EQRO contractor across multiple western and southwestern states. It is a direct competitor to IPRO in federal and state healthcare quality improvement procurements with comparable services.

Broad incumbents

  • Centers for Medicare & Medicaid Services (CMS): CMS is the federal agency that funds and oversees IPRO's largest contracts (QIN-QIO, ESRD Networks). While not a commercial competitor, CMS shapes the regulatory environment IPRO operates within and represents the dominant counterparty in IPRO's revenue model.
  • Mathematica: Mathematica is a major US policy research and data analytics firm that performs healthcare quality measurement, program evaluation, and CMS technical assistance work. It is comparable to IPRO in healthcare analytics and federal government contracts but operates more broadly across policy areas.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

IPRO social profiles

Digital presence

IPRO compliance and trust

Trust signal

Compliance3 records

IPRO financial estimates

Financial estimate

Revenue estimate

Valuation estimate

IPRO leadership team

Management profile

Number of profiles

Profiles13 records

IPRO subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

IPRO funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

IPRO M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IPRO

What does IPRO do?

IPRO is a non-profit healthcare quality improvement organization that delivers contracted services to federal and state governments, healthcare providers, and managed care plans. Its core offerings include the Medicare Quality Innovation Network-Quality Improvement Organization (QIN-QIO) program for CMS Regions 1 and 2, ESRD Network Programs for End-Stage Renal Disease patients, External Quality Review Organization (EQRO) services for state Medicaid programs, Independent Dispute Resolution under the No Surprises Act, Independent Review of Appeals, and supporting digital tools such as the Kidney Transplant Compare mobile application.

Is IPRO a public or private company?

IPRO is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was IPRO founded?

IPRO was founded in 1984. It employs 251 to 500 people.

Where is IPRO based?

IPRO is headquartered in New Hyde Park, United States, in the North America region.

How does IPRO make money?

Four revenue lines are on record. Federal Government Contracts are the primary driver. The others are state Government Contracts, external Quality Review Organization (EQRO) and healthcare Quality Improvement Consulting.

Who are IPRO's main competitors?

IMPAQ International is listed as an emerging player. Direct peers are MetaStar, Stratis Health, Qlarant, Telligen, Healthcentric Advisors, Alliant Health Solutions and Health Services Advisory Group (HSAG). Broad incumbents are Centers for Medicare & Medicaid Services (CMS) and Mathematica.

Does IPRO have an API?

No public API is recorded for IPRO.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Current NewsSelect Vermont healthcare providers eligible for no-cost Quality Improvement ProgramIPRO, a national not-for-profit healthcare organization, was awarded a contract by the Centers for Medicare & Medicaid Services (CMS) to serve as the Quality Innovation Network-Quality Improvement Organization (QIN-QIO) for the Northeast Region, covering Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, Connecticut, New York, New Jersey, Puerto Rico and the Virgin Islands, with the contract running through May 2030. Under this contract, IPRO and its subcontractors Healthcentric Advisors and Qlarant will work directly with nursing homes, hospitals, and outpatient clinical practices to improve the quality and safety of care for approximately 24 percent of the nation's Medicare beneficiaries. The contract builds on IPRO's previous QIN-QIO work in the Mid-Atlantic Region, where it had previously served, and focuses on areas including chronic disease management, quality and patient safety, behavioral health, care coordination, and technology adoption.PR NewswireIPRO Executive Joins National Quality Forum CommitteeSusan Caponi, CEO of IPRO's End-Stage Renal Disease Network Program, has been appointed to the National Quality Forum's Rural Telehealth and Healthcare System Readiness Committee, which is developing a measurement framework linking telehealth quality, healthcare system readiness, and health outcomes during emergencies. The committee's work, funded by the Centers for Medicare & Medicaid Services, aims to document changes to telehealth measures and propose new priority measures for rural communities. IPRO's ESRD Network Program supports over 132,000 renal patients across 13 states and assists dialysis facilities during disasters and emergencies.PR NewswireIPRO Takes Over Rhode Island Hospital Review ActivityIPRO has assumed responsibility for Medicaid acute care hospital utilization review in Rhode Island, effective this month, under a contract with the state's Executive Office of Health & Human Services. The organization will oversee services at 12 hospitals and three healthcare systems, taking over duties from the previous contractor Qualidigm of Connecticut. IPRO, a national not-for-profit healthcare quality improvement organization, will conduct screenings, concurrent review, retrospective analysis, and prior approval of admissions, building on its existing quality review work in the state since 2003.PR NewswireIPRO to Provide Hospital Quality Improvement Services for the Centers for Medicare & Medicaid ServicesThe Centers for Medicare & Medicaid Services (CMS) awarded a four-year contract to IPRO to serve as a Hospital Quality Improvement Contractor (HQIC) within its Network of Quality Improvement and Innovation Contractors (NQIIC). IPRO will provide targeted quality improvement assistance to small, rural, critical access hospitals, and those hospitals identified by CMS as requiring technical assistance. The assistance will focus on infection control, pandemic readiness and response, the opioid epidemic, and patient safety for Medicare beneficiaries.PR NewswireAAKP Recognizes IPRO ESRD Network of the South Atlantic for Service to the Kidney Patient CommunityThe IPRO End Stage Renal Disease (ESRD) Network of the South Atlantic received the 2020 Dominick Gentile, MD, Memorial Award from the American Association of Kidney Patients (AAKP). The recognition highlights the network's contributions to patient-centered outcomes research and its leadership within the Southeastern Kidney Transplant Coalition. IPRO manages four such networks serving over 132,000 renal patients across 13 states under CMS direction.PR NewswireSenior IPRO Executive Chosen Chair of Accreditation GroupHarry M. Feder, Chief Operating Officer of IPRO, has been elected Board Chair of URAC, a leading national healthcare accreditation organization, representing the American Health Quality Association on the board. Feder oversees more than 200 professionals with federal and state contracts spanning over twenty states and the District of Columbia. The appointment reflects Feder's expertise in utilization management and healthcare quality improvement, with URAC's CEO noting his broad experience makes him an ideal fit for the leadership role.PR NewswireEarly Research Doubts Benefit of COVID-19 Drug TreatmentA retrospective study published in the Journal of the American Medical Association found that hospitalized COVID-19 patients treated with hydroxychloroquine and/or azithromycin showed no mortality benefit compared to 1,438 patients receiving neither drug, with overall in-hospital mortality at 20.3%. Researchers from the University at Albany School of Public Health, the New York State Department of Health, IPRO, and Downstate Health Sciences University examined patients at 25 New York metropolitan area hospitals and found cardiac arrest was significantly more likely among patients receiving both drugs together. The authors noted no disparities in prescribing between white and minority patients, which they said was relevant given previously reported population-level differences in COVID-19 deaths by race and ethnicity.PR NewswireIPRO Creates Kidney Disease Management ToolsIPRO, a non-profit healthcare organization, launched two mobile applications for chronic kidney disease management—a physician-facing CKD Screening App and a patient-facing Kidney Choices app. The apps interface with the federal government's Blue Button 2.0 Initiative, providing access to up to four years of Medicare claims history and educational resources on treatment options including dialysis and kidney transplant. The freely available, HIPAA-compliant applications aim to enhance data-driven decision-making and patient education for CKD care.GlobeNewswireQlarant Selected by IPRO to support QIN-QIO Task OrderQlarant was selected as a subcontractor to IPRO to support a CMS QIN-QIO contract awarded on November 8, 2019. The five-year contract covers quality improvement in nursing homes and small/rural practices across multiple states. Qlarant's CEO expressed gratitude for the opportunity.PR NewswireIPRO Awarded Five-Year Federal Quality Innovation ContractThe Centers for Medicare & Medicaid Services selected IPRO as a Prime Awardee of the Network of Quality Improvement and Innovation Contractor program, enabling IPRO to bid on Task Orders over the next five years. As an NQIIC awardee, IPRO will provide quality improvement expertise, serve as facilitators for healthcare transformation, and offer services including technical assistance in areas such as patient safety, opioid misuse, and nursing home quality. This designation confirms IPRO's demonstrated capability to successfully address CMS' strategic goals and bold priorities planned over the five-year contract period.